MBRX
Moleculin Biotech, Inc.
Latest Form 4:Purchase—byKLEMP WALTER V (CEO and President) · filed Aug 5, 2026
Moleculin Biotech, Inc. (MBRX) has 6 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.
- Industry:Biotechnology
- CEO:Walter V. Klemp
- Employees:17
- HQ:Houston, TX, US
- IPO:2016-06-02
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$3.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
KLEMP WALTER VFirst filing | CEO and President | Purchase | 533,333 | — | Aug 5 | SEC ↗ |
Foster Jonathan P.First filing | Chief Financial Officer | Purchase | 293,333 | — | Aug 5 | SEC ↗ |
PICKER DONALD HFirst filing | Chief Science Officer | Purchase | 173,333 | — | Aug 5 | SEC ↗ |
Related companies
Moleculin Biotech, Inc. is in the Healthcare sector.